Wael Khoury, MD

Appointed
1982

Education & Fellowships

Fellowship - University Hospitals of Cleveland
Cardiovascular Diseases
Cleveland, OH
1981

Residency - Saint Luke's Medical Center
Internal Medicine
Cleveland, OH
1979

Residency - Huron Hospital
Internal Medicine
Cleveland, OH
1978

Internship - Huron Hospital
Internal Medicine
Cleveland, OH
1977

Medical Education - Damascus University-Faculty of Medicine
Damascus,
1975

Professional Highlights

• Leading the Cardiology program at Marymount since 1982.

  Lobbied the ODH and the State of Ohio to allow Hospitals less than 250 beds to have a level one diagnostic cardiac cath labs. 25 Hospitals in Ohio opened up cath. labs, 4 of them are in the Cleveland Clinic System.

  Working with Dr. James Young on the CHF CCF Ad Hoc committee we received the Codman Award by the joint Commission in 2001, which was the first of its kind to a large hospital system in the US.

  I spear headed and established a CCHS CRO for the East side Hospitals, 2002-2011. Several Clinical research projects went through the CRO for several years. It was then folded into the CCF CRO.

  Working with Dr. Randall Starling, we initiated an Ad Hoc committee to establish the H to H program for CCHS. It then got folded into the general Quality Improvement programs of the system.

  As the CMO at that time, I was on the early negotiation steps that lead to Marymount joining the Cleveland Clinic in 1995. I played an active part in the process.

  Consequently, I was a member of the Medical Operations Council of CCHS for many years, even after changing its name and structure, up to 2017.

Certifications

• Internal Medicine - Cardiovascular Disease
• Internal Medicine

Awards & Honors

• Received several awards and Honors on all the above mentioned projects and positions.

Innovations & Patents

• None

Memberships

• AHA

  ACC

See publications for Wael Khoury, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/25/2025, Dr. Khoury has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.